Entity family

Browse funders

Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.

3articles mentioning funders

5funder mentions

1distinct funders extracted

0%of mentions human-reviewed

Active filtersEntity: Pfizer ×

Pfizer

This funder is selected. Its supporting articles are shown below.

Articles mentioning Pfizer

3 articles · page 1 of 1

191 Tumor microenvironment changes after treatment with avelumab combinations in patients with advanced solid tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

92.3%

Pfizer avelumab utomilumab PF-04518600 The University of Texas MD Anderson Cancer Center solid tumors anti-OX40 anti-4-1BB OX40 colorectal and pancreatic cancers

…03217747Acknowledgements The study was financially supported by Pfizer as part of a previous alliance between Pfizer and the healthcar…

53 Assessing the mechanism of action (MOA) of tisotumab vedotin (TV) in head and neck squamous cell carcinoma (HNSCC) with digital pathology analysis of H&E images from innovaTV207 part C

jitc · abstract · 2025-11-04 · 2 matching annotations

87.3%

Pfizer Seagen Inc.Genmab Tisotumab vedotin HNSCC Nucleus Global antibody-drug conjugate (ADC) therapies

…ers of tisotumab vedotin. Medical writing assistance, funded by Pfizer according to Good Publication Practice guidelines, was provided…

Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland

archdischild · abstract · 2026-06-22 · 1 matching annotations

94.3%

Pfizer palivizumab bronchiolitis lower respiratory tract infections Respiratory syncytial virus lower respiratory tract infection Abrysvo antenatal education

…izumab. In August 2024, the UK introduced the RSVpreF (Abrysvo, Pfizer) maternal vaccine into its national immunisation schedule. The …